TRLS.L
Price:
$1.848
Market Cap:
$3.80M
Trellus Health plc provides digital chronic condition management solutions for employers and health plans. The company offers TrellusElevate, a proprietary HIPAA-compliant technology platform to coordinate and deliver personalized care remotely through telemedicine. Its platform provides patients with access to a care team, educational content resources, and remote monitoring capabilities for the treatment of inflammatory bowel diseases, which include the chronic incurable conditions of Crohn's Disease and ulcerative colitis. The company was founded in 2020 and is headquartered in White Plains, New York.[Read more]
Industry
Medical - Healthcare Information Services
IPO Date
2021-05-31
Stock Exchange
LSE
Ticker
TRLS.L
According to Trellus Health plc’s latest financial reports and current stock price. The company's current Current Ratio is 14.14. This represents a change of -35.73% compared to the average of 22.00 of the last 4 quarters.
The mean historical Current Ratio of Trellus Health plc over the last ten years is 22.71. The current 14.14 Current Ratio has changed 6.13% with respect to the historical average. Over the past ten years (40 quarters), TRLS.L's Current Ratio was at its highest in in the June 2021 quarter at 38.77. The Current Ratio was at its lowest in in the June 2020 quarter at 0.
Average
22.71
Median
22.44
Minimum
15.69
Maximum
30.29
Discovering the peaks and valleys of Trellus Health plc Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 10.50%
Maximum Annual Current Ratio = 30.29
Minimum Annual Increase = -33.43%
Minimum Annual Current Ratio = 15.69
Year | Current Ratio | Change |
---|---|---|
2023 | 15.69 | -33.43% |
2022 | 23.56 | 10.50% |
2021 | 21.32 | -29.60% |
The current Current Ratio of Trellus Health plc (TRLS.L) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
20.19
5-year avg
22.71
10-year avg
22.71
Trellus Health plc’s Current Ratio is greater than Verici Dx plc (4.54), greater than EKF Diagnostics Holdings plc (4.60), greater than Renalytix Plc (0.53), greater than Belluscura plc (3.25), less than Poolbeg Pharma PLC (19.61),
Company | Current Ratio | Market cap |
---|---|---|
4.54 | $9.06M | |
4.60 | $93.01M | |
0.53 | $27.82M | |
3.25 | $2.56M | |
19.61 | $12.74M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Trellus Health plc using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Trellus Health plc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Trellus Health plc's Current Ratio?
How is the Current Ratio calculated for Trellus Health plc (TRLS.L)?
What is the highest Current Ratio for Trellus Health plc (TRLS.L)?
What is the 3-year average Current Ratio for Trellus Health plc (TRLS.L)?
What is the 5-year average Current Ratio for Trellus Health plc (TRLS.L)?
How does the current Current Ratio for Trellus Health plc (TRLS.L) compare to its historical average?